PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Digoxin increases deaths in patients with atrial fibrillation

2012-11-28
(Press-News.org) Digoxin, a drug that has been used worldwide for centuries to treat heart disease, is associated with a significant increase in deaths in patients with atrial fibrillation (AF), according to results from a study published online today (Wednesday) in the European Heart Journal [1].

Digoxin is extracted from the foxglove plant (digitalis) and it helps the heart beat more strongly and with a more regular rhythm. It is commonly used in AF patients, and also in patients with heart failure. However, it can be problematic to use successfully as there is a narrow dose range at which it is effective and beyond which it can be dangerous. High levels of digoxin in the blood have been correlated with an increased death rate in patients.

Researchers led by Samy Claude Elayi, associate professor of medicine at the Gill Heart Institute, University of Kentucky, USA, analysed data from 4,060 AF patients who had enrolled in the landmark Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial in order to determine the relationship between digoxin and deaths in this group of patients.

They found that digoxin was associated with a 41% increase in deaths from any cause, after controlling for other medications and risk factors, and that an increase in deaths occurred regardless of gender or the presence or absence of underlying heart failure. Digoxin was also associated with a 35% increase in deaths from cardiovascular causes, and a 61% increase in deaths from arrhythmias (problems with the rate or rhythm of the heart beat).

Professor Elayi said: "These results mean that among AF patients taking digoxin compared to those not on digoxin in the AFFIRM trial, within five years one additional patient out of six will die from any cause, one additional patient out of eight will die from cardiovascular causes, and one additional patient out of 16 will die from arrhythmias.

"These findings call into question the widespread use of digoxin in patients with AF, particularly when used for controlling AF rate in a similar way as in the AFFIRM trial."

Until now, there have been limited data on the use of digoxin in AF patients. "Digoxin in AF patients has hardly been studied," said Prof Elayi. "The main prospective randomised controlled trials available with digoxin were performed in patients with heart failure and sinus rhythm, excluding AF patients."

As a result of these findings, the authors conclude in their paper: "Our study underscores the importance of reassessing the role of digoxin in the contemporary management of AF in patients with or without HF."

Prof Elayi said: "These findings mean that physicians should try to control a patient's heart rate by using alternatives as a first line, such as beta-blockers or calcium blockers; if digoxin is used, use a low dose with careful clinical follow-up, evaluate potential drug interactions when starting new medications, and monitor digoxin levels. Patients should be aware of potential toxicity and see their physicians immediately in specific clinical situations, for instance if they experience palpitations or syncope, as those may precede arrhythmic death."

The researchers say that the mechanism by which digoxin increases deaths among patients is unclear. "Deaths from classic cardiovascular causes, whether due to arrhythmia or not, can partly but not entirely explain it. This suggests there must be some additional mechanism that remains to be identified," said Prof Elayi.

He concluded: "There is a need for further studies of the drug's use, particularly in systolic heart failure patients and AF – patients that would, in theory, benefit the most from digoxin."

### Notes: [1] "Increased mortality among patients takng digoxin-analysis: analysis from the AFFIRM study", by Matthew G. Whitbeck et al. European Heart Journal. doi:10.1093/eurheartj/ehs348.


ELSE PRESS RELEASES FROM THIS DATE:

Thyroid problems linked to irregular heart rhythm

2012-11-28
People with an overactive thyroid gland (hyperthyroidism) carry a greater risk of developing irregular heart rhythm (known as atrial fibrillation) than those with normal thyroid function, finds a study published on bmj.com today. As such, the researchers suggest there should be an increased focus on atrial fibrillation in patients with raised thyroid function. Hyperthyroidism occurs when the thyroid gland makes too much thyroxine (thyroid hormone), causing many of the body's functions to speed up. About 1 in 100 women and 1 in 1,000 men develop hyperthyroidism at some ...

One child mothers with pre-eclampsia at higher risk of heart problems

2012-11-28
Women who develop pre-eclampsia during their first pregnancy (known as preterm pre-eclampsia) - and who don't go on to have any more children – are at greater risk of dying from heart disease in later life than women who have subsequent children, finds a study published on bmj.com today. Women who develop the condition only in the final weeks of pregnancy (known as term pre-eclampsia) are at less risk. This high risk to one child mothers has not been previously reported and suggests that these women need special monitoring, especially if their pre-eclampsia was preterm. ...

Projected sea-level rise may be underestimated

2012-11-28
That sea level is rising faster than expected could mean that the Intergovernmental Panel on Climate Change's (IPCC) sea-level rise projections for the future may be biased low as well, their results suggest. Sea-level rise potentially affects millions of people all around the world in coastal areas as well as megacities like Tokyo. "Global temperature continues to rise at the rate that was projected in the last two IPCC Reports. This shows again that global warming has not slowed down or is lagging behind the projections," Rahmstorf says. Five global land and ocean ...

Malaria study suggests drugs should target female parasites

2012-11-28
Fresh insight into the parasite that causes malaria suggests a new way to develop drugs and vaccines to tackle the disease. Research into malaria parasites – which exist in male and female forms, and mate to spread the disease – suggests that treatments would be more likely to succeed if designed to target female forms of the parasite. Scientists found that male parasites can adapt to new surroundings faster than the females. When malaria infects the bloodstream after a mosquito bite, the male parasites are better able to react quickly to repeated attacks by the immune ...

For some feathered dinosaurs, bigger not necessarily better

For some feathered dinosaurs, bigger not necessarily better
2012-11-28
Every kid knows that giant carnivores like Tyrannosaurus rex dominated the Cretaceous period, but they weren't the only big guys in town. Giant plant-eating theropods – close relatives of both T. rex and today's birds – also lived and thrived alongside their meat-eating cousins. Now researchers have started looking at why dinosaurs that abandoned meat in favor of vegetarian diets got so big, and their results may call conventional wisdom about plant-eaters and body size into question. Scientists have theorized that bigger was better when it came to plant eaters, because ...

Compound found in rosemary protects against macular degeneration in laboratory model

Compound found in rosemary protects against macular degeneration in laboratory model
2012-11-28
LA JOLLA, Calif., November 27, 2012 – Herbs widely used throughout history in Asian and early European cultures have received renewed attention by Western medicine in recent years. Scientists are now isolating the active compounds in many medicinal herbs and documenting their antioxidant and anti-inflammatory activities. In a study published in the journal Investigative Ophthalmology & Visual Science, Stuart A. Lipton, M.D., Ph.D. and colleagues at Sanford-Burnham Medical Research Institute (Sanford-Burnham) report that carnosic acid, a component of the herb rosemary, promotes ...

Increasing drought stress challenges vulnerable hydraulic system of plants, GW professor finds

2012-11-28
WASHINGTON - The hydraulic system of trees is so finely-tuned that predicted increases in drought due to climate change may lead to catastrophic failure in many species. A recent paper co-authored by George Washington University Assistant Professor of Biological Sciences Amy Zanne finds that those systems in plants around the globe are operating at the top of their safety threshold, making forest ecosystems vulnerable to increasing environmental stress. In the current issue of the journal Nature, Dr. Zanne and lead authors from the University of Western Sydney in Australia ...

GSA Today: Human transformation of land threatens future sustainability?

GSA Today: Human transformation of land threatens future sustainability?
2012-11-28
Boulder, Colorado, USA - Social and physical scientists have long been concerned about the effects of humans on Earth's surface -- in part through deforestation, encroachment of urban areas onto traditionally agricultural lands, and erosion of soils -- and the implications these changes have on Earth's ability to provide for an ever-growing population. The December 2012 GSA Today science article presents examples of land transformation by humans and documents some of the effects of these changes. Researchers Roger Hooke of the University of Maine, USA, and José F. Martín-Duque ...

Resolving conflicts over end-of-life care: Mayo experts offer tips

2012-11-28
ROCHESTER, Minn. -- It's one of the toughest questions patients and their loved ones can discuss with physicians: When is further medical treatment futile? The conversation can become even more difficult if patients or their families disagree with health care providers' recommendations on end-of-life care. Early, clear communication between patients and their care teams, choosing objective surrogates to represent patients and involving third parties such as ethics committees can help avoid or resolve conflicts, Mayo Clinic experts Christopher Burkle, M.D., J.D., and Jeffre ...

How to buy an ethical diamond

2012-11-28
BUFFALO, N.Y. -- You've already decided that you're going to pop the question. Now comes another quandary: Where to get the ring, if you're buying one? The holidays are a busy time for engagements, and Trina Hamilton, a University at Buffalo expert in corporate responsibility, says socially minded consumers have a lot to think about when it comes to finding the right rock. In recent years, shoppers have turned to Canadian diamonds as news reports and movies exposed the diamond trade's role in fueling armed conflicts in developing countries. (Think "Blood Diamond," the ...

LAST 30 PRESS RELEASES:

Modeling and analysis reveals technological, environmental challenges to increasing water recovery from desalination

Navy’s Airborne Scientific Development Squadron welcomes new commander

TāStation®'s analytical power used to resolve a central question about sweet taste perception

NASA awards SwRI $60 million contract to develop next-generation coronagraphs

Reducing antimicrobial resistance: accelerated efforts are needed to meet the EU targets

Gaming for the good!

Early adoption of sodium-glucose cotransporter-2 inhibitor in patients hospitalized with heart failure with mildly reduced or preserved ejection fraction

New study finds atrial fibrillation common in newly diagnosed heart failure patients, and makes prognosis significantly worse

Chitnis receives funding for study of wearable ultrasound systems

Weisburd receives funding for safer stronger together initiative

Kaya advancing AI literacy

Wang studying effects of micronutrient supplementation

Quandela, the CNRS, Université Paris-Saclay and Université Paris Cité join forces to accelerate research and innovation in quantum photonics

Pulmonary vein isolation with optimized linear ablation vs pulmonary vein isolation alone for persistent AF

New study finds prognostic value of coronary calcium scores effective in predicting risk of heart attack and overall mortality in both women and men

New fossil reveals the evolution of flying reptiles

Redefining net zero will not stop global warming – scientists say

Prevalence of cardiovascular-kidney-metabolic syndrome stages by social determinants of health

Tiny worm makes for big evolutionary discovery

Cause of the yo-yo effect deciphered

Suicide rates for young male cancer survivors triple in recent years

Achalasia and esophageal cancer: A case report and literature review

Authoritative review makes connections between electron density topology, future of materials modeling and how we understand mechanisms of phenomena in familiar devices at the atomistic level

Understanding neonatal infectious diseases in low- and middle-income countries: New insights from a 30-year study

This year’s dazzling aurora produced a spectacular display… of citizen science

New oral drug to calm abdominal pain

New framework champions equity in AI for health care

We finally know where black holes get their magnetic fields: Their parents

Multiple sclerosis drug may help with poor working memory

The MIT Press releases workshop report on the future of open access publishing and policy

[Press-News.org] Digoxin increases deaths in patients with atrial fibrillation